» Authors » J Brettschneider

J Brettschneider

Explore the profile of J Brettschneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 448
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brettschneider J, Irwin D, Boluda S, Byrne M, Fang L, Lee E, et al.
Neuropathol Appl Neurobiol . 2016 Oct; 43(4):315-329. PMID: 27716988
Aims: The aim of this study was to identify early foci of α-synuclein (α-syn pathology) accumulation, subsequent progression and neurodegeneration in multiple system atrophy of the cerebellar type (MSA-C). Methods:...
2.
Miller V, Lin A, Kako F, Gabunia K, Kelemen S, Brettschneider J, et al.
Phys Plasmas . 2015 Nov; 22(12):122005. PMID: 26543345
Angiogenesis is the formation of new blood vessels from pre-existing vessels and normally occurs during the process of inflammatory reactions, wound healing, tissue repair, and restoration of blood flow after...
3.
Ludolph A, Brettschneider J
Eur J Neurol . 2015 Apr; 22(5):753-61. PMID: 25846565
Amyotrophic lateral sclerosis is a devastating disease characterized by rapidly progressive paresis. The neuropathological hallmark of most amyotrophic lateral sclerosis cases are neuronal and glial aggregates of phosphorylated 43-kDa TAR...
4.
Sussmuth S, Brettschneider J, Spreer A, Wick M, Jesse S, Lewerenz J, et al.
Nervenarzt . 2013 Feb; 84(2):229-44. PMID: 23371378
Cerebrospinal fluid (CSF) analysis is of utmost importance to establish an early diagnosis of central nervous system (CNS) infections and to start appropriate therapy. The CSF white cell count, lactate...
5.
Tumani H, Petzold A, Wick M, Kuhn H, Uhr M, Otto M, et al.
Nervenarzt . 2010 Aug; 81(8):973-9. PMID: 20700683
The diagnostic investigation of CT-negative subarachnoid haemorrhage (SAH) is a particular challenge in clinical neurology. Cerebrospinal fluid (CSF) analysis via lumbar puncture is the method of choice. The diagnosis of...
6.
Sussmuth S, Sperfeld A, Hinz A, Brettschneider J, Endruhn S, Ludolph A, et al.
Neurology . 2010 Mar; 74(12):982-7. PMID: 20308682
Background: In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), CSF biomarkers are increasingly studied to evaluate their relevance for differential diagnosis, disease progression, and understanding of pathophysiologic processes. Objective:...
7.
Petzold A, Chapman M, Schraen S, Verwey N, Pasquier F, Bombois S, et al.
Exp Neurol . 2009 Dec; 223(2):432-8. PMID: 20005225
Newly proposed diagnostic criteria for Alzheimer's disease include cerebrospinal fluid (CSF) tau levels as one core supportive criterion. The published high sensitivity and specificity figures for CSF tau levels in...
8.
Petzold A, Brettschneider J, Jin K, Keir G, Murray N, Hirsch N, et al.
Muscle Nerve . 2009 Jun; 40(1):42-9. PMID: 19533642
Early predictors of prognosis in Guillain-Barré syndrome (GBS) are needed to identify patients who are likely to make a poor recovery and to guide therapeutic decision-making in the acute phase....
9.
Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, et al.
Neurosci Lett . 2009 Apr; 452(2):214-7. PMID: 19383442
Cerebrospinal fluid (CSF) is a promising source of biomarkers in clinically isolated syndrome (CIS), which frequently presents as a first episode of multiple sclerosis (MS). Using the two-dimensional difference in...
10.
Beinhoff U, Tumani H, Brettschneider J, Bittner D, Riepe M
J Neurol . 2008 Jan; 255(1):117-22. PMID: 18202815
Background: Amnestic Mild Cognitive Impairment (MCI) is a condition with an increased risk for developing Alzheimer's disease (AD). Presently, gender differences are neglected in the assessment of MCI and AD....